Lomond Therapeutics Holdings, Inc.: key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2025)
- -$23.5M
- Total Assets (FY2025)
- $30.8M
- Total Equity (FY2025)
- $21.3M
- Cash Flows from Operating Activities (FY2025)
- -$22.8M
Source: Lomond Therapeutics Holdings, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
